Salona Global Medical Device Corporation (LNDZF)
| Previous Close | 0.2700 |
| Open | 0.2700 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2700 - 0.2700 |
| 52 Week Range | 0.2600 - 0.6850 |
| Volume | |
| Avg. Volume | 4,712 |
| Market Cap | 15.694M |
| Beta (5Y Monthly) | 1.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings Date | May 30, 2023 - Jun 05, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 24, 2017 |
| 1y Target Est | N/A |
- GlobeNewswire
Salona Global Plans to Close the Acquisition of the Physical Medicine Business of Biodex on April 3, 2023; Engages Maxim Group LLC as Exclusive Investment Banking Advisor for US Capital Markets
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global,” “SGMD,” or the “Company”) (TSXV:SGMD) announced that it executed a stock purchase agreement (the “Agreement”) to purchase all of the shares of capital stock of Biodex Medical Systems, Inc. (“Biodex”), which consists principally of the Biodex Physical Medicine (Rehabilitation) business (the “Acquisition”). The Agreement replaces the previously disclosed asset purchase agreement covering the
- Newsfile
Gap Partners, Inc. Files Early Warning Report in Respect of Securities of Salona Global Medical Device Corporation
Athens, Georgia--(Newsfile Corp. - March 13, 2023) - Gap Partners, Inc. ("GPI"), a corporation existing under the laws of the State of Georgia controlled by Luke Faulstick and Stephen Hollis, announces that on May 21, 2021 it completed a transaction with Salona Global Medical Device Corporation ("Salona") pursuant to which Brattle Acquisition I Corp. (the "Subsidiary"), a South Dakota corporation and wholly-owned subsidiary of Salona, acquired all of the issued and outstanding shares of ...
- GlobeNewswire
Salona Global Provides Acquisitions Update, Highlights from U.S. Roadshow Presentation
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global,” “SGMD ,” or the “Company”) (TSXV:SGMD) today provided an update to its acquisition plans and pipeline. The Company is also publishing an up-to-date presentation for upcoming meetings with U.S. institutional investors. In addition to the pending acquisition of Biodex Medical Systems, Inc. (“Biodex”), previously announced November 29, 2022, that the Company is currently working to close, the
